Bunkyo, Japan

Atsushi Kaneda

This inventor holds 1 USPTO granted patent. Top assignees: Sysmex Corporation, The University of Tokyo. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Atsushi Kaneda. Retrieved from https://idiyas.com/inventor/atsushi-kaneda-vifaf14i

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Atsushi Kaneda: Innovator in Cancer Detection

Introduction

Atsushi Kaneda is a notable inventor based in Bunkyo, Japan. He has made significant contributions to the field of cancer research, particularly in the detection of cancer cells through innovative methods. His work has the potential to improve the prognosis for patients suffering from colorectal cancer.

Latest Patents

Atsushi Kaneda holds a patent for a method of methylation analysis to determine the presence of cancer cells. This invention relates to a technique for assessing the presence or absence of cancer cells in biological samples. It also provides a method for determining the prognosis of colorectal cancer patients by analyzing the methylation status of a marker gene extracted from DNA.

Career Highlights

Throughout his career, Kaneda has worked with prestigious institutions, including The University of Tokyo and Sysmex Corporation. His experience in these organizations has allowed him to develop and refine his innovative approaches to cancer detection.

Collaborations

Some of his notable coworkers include Ayako Sakai and Kouichi Yagi. Their collaboration has contributed to the advancement of research in cancer diagnostics.

Conclusion

Atsushi Kaneda's work in cancer detection exemplifies the impact of innovative thinking in medical research. His contributions are paving the way for improved diagnostic methods and better patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…